Evidence map›Paper›PMID 19450519›Full record

ArticleCell2009

Hematopoietic stem cell development is dependent on blood flow.

Trista E North, Wolfram Goessling, Marian Peeters, Pulin Li, Craig Ceol, Allegra M Lord, Gerhard J Weber, James Harris, Claire C Cutting, Paul Huang and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 249 papers.

0numbers the graph read from it
0cells of the map it votes in
249citing papers in PubMed
16.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

249 citing papers in PubMed, 437 citations in OpenAlex.

  1. Article
  2. Article
  3. Mechanometabolism instructs hematopoietic stem cell specification.The Journal of experimental medicine · 2026
    Article
  4. Article
  5. Review
  6. Blood Flow Regulates Metabolism in Hematopoietic Development.Advances in experimental medicine and biology · 2026
    Review
  7. Swimming motions evoke Piezo1-dependent CaCurrent biology : CB · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

189 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Trista E NorthStem Cell Program and Hematology/Oncology, Children's Hospital, Howard Hughes Medical Institute, Harvard Stem Cell Institute, Harvard Medical School, Boston, MA 02115, USA.
Wolfram Goessling
Marian Peeters
Pulin Li
Craig Ceol
Allegra M Lord
Gerhard J Weber
James Harris
Claire C Cutting
Paul Huang
Elaine Dzierzak
Leonard I Zon
Howard Hughes Medical Institute · USErasmus MC Cancer Institute · NLHarvard Stem Cell Institute · USBeth Israel Deaconess Medical Center · USBrigham and Women's Hospital · USMassachusetts General Hospital · US

Funding

EMBRYONIC HEMATOPOIESISR01HL048801 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI ZON, LEONARD IRA · 1992 to 2016
$5.7M
Characterization of the first HSCs during mouse ontogenyR37DK054077 · NIDDK · UNIVERSITY OF EDINBURGH · PI DZIERZAK, ELAINE A · 2006 to 2015
$2.7M
Howard Hughes Medical InstituteNHLBI NIH HHS R01 HL048801NIDDK NIH HHS R37 DK054077
6 · The paper itself

Abstract

During vertebrate embryogenesis, hematopoietic stem cells (HSCs) arise in the aorta-gonads-mesonephros (AGM) region. We report here that blood flow is a conserved regulator of HSC formation. In zebrafish, chemical blood flow modulators regulated HSC development, and silent heart (sih) embryos, lacking a heartbeat and blood circulation, exhibited severely reduced HSCs. Flow-modifying compounds primarily affected HSC induction after the onset of heartbeat; however, nitric oxide (NO) donors regulated HSC number even when treatment occurred before the initiation of circulation, and rescued HSCs in sih mutants. Morpholino knockdown of nos1 (nnos/enos) blocked HSC development, and its requirement was shown to be cell autonomous. In the mouse, Nos3 (eNos) was expressed in HSCs in the AGM. Intrauterine Nos inhibition or embryonic Nos3 deficiency resulted in a reduction of hematopoietic clusters and transplantable murine HSCs. This work links blood flow to AGM hematopoiesis and identifies NO as a conserved downstream regulator of HSC development.

Indexed as

Blood Physiological PhenomenaHematopoiesisAnimalsEmbryo, MammalianEmbryo, NonmammalianHematopoietic Stem CellsMiceMice, Inbred C57BLNitric OxideNitric Oxide Synthase Type IIIZebrafishNitric OxideNitric Oxide Synthase Type III

Identifiers

PMID19450519
PMCPMC2722870
OpenAlexW2131404238

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.